Aclaris Therapeutics (ACRS) Current Leases (2017 - 2023)
Aclaris Therapeutics (ACRS) posted quarterly Current Leases of $426000.0 for Q4 2023, down 37.72% year-over-year from $684000.0 in Q4 2022, and up 37.42% quarter-over-quarter from $310000.0 in Q3 2023.
Powered by 
Analysis
Aclaris Therapeutics (ACRS) Current Leases (2017 - 2023) Analysis & Trends
Aclaris Therapeutics' Current Leases history runs 5 years deep, the most recent figure standing at $426000.0 for Q4 2023.
- In Q4 2023, Current Leases fell 37.72% year-over-year to $426000.0; the TTM figure through Dec 2023 stood at $426000.0 (down 37.72% YoY), while the FY2023 annual figure was $426000.0, down 37.72% from the prior year.
- Current Leases for Q4 2023 stood at $426000.0, up from $310000.0 in the prior quarter.
- The five-year high for Current Leases was $766000.0 in Q3 2022, with the low at $310000.0 in Q3 2023.
- The 3-year median for Current Leases is $643500.0 (2022), against an average of $585125.0.
- The sharpest annual moves came in 2022 and 2023: Current Leases retreated 1.3% in 2022, then sank 59.53% in 2023.
- Aclaris Therapeutics' Current Leases stood at $693000.0 in 2021, then declined by 1.3% to $684000.0 in 2022, then slumped by 37.72% to $426000.0 in 2023.
- Business Quant data shows ACRS's Current Leases at $426000.0 in Q4 2023, $310000.0 in Q3 2023, and $458000.0 in Q2 2023.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 720.00 Mn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 11.00 Mn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 16.75 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 21.95 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 45.93 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 6.27 Mn |
| 10 | Aclaris Therapeutics | 882.83 Mn | 882.83 Mn | 1.41 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2023 | 426,000.00 |
| Sep 30, 2023 | 310,000.00 |
| Jun 30, 2023 | 458,000.00 |
| Mar 31, 2023 | 603,000.00 |
| Dec 31, 2022 | 684,000.00 |
| Sep 30, 2022 | 766,000.00 |
| Jun 30, 2022 | 741,000.00 |
| Dec 31, 2021 | 693,000.00 |
| Dec 31, 2018 | 601,000.00 |
| Sep 30, 2018 | 591,000.00 |
| Jun 30, 2018 | 552,000.00 |
| Mar 31, 2018 | 142,000.00 |
| Dec 31, 2017 | 142,000.00 |